Legal Representation
Attorney
Kevan L. Morgan
USPTO Deadlines
Next Deadline
585 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-03-09)
Due Date
March 09, 2027
Grace Period Ends
September 09, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
37 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Mar 9, 2021 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Dec 22, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Dec 22, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Dec 2, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Nov 13, 2020 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Nov 13, 2020 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Nov 13, 2020 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Nov 13, 2020 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
Nov 13, 2020 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Nov 12, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Nov 12, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Nov 3, 2020 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
Aug 21, 2020 | GNS2 | O | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | Loading... |
Aug 21, 2020 | GNSI | S | INQUIRY TO SUSPENSION E-MAILED | Loading... |
Aug 21, 2020 | CNSI | R | SUSPENSION INQUIRY WRITTEN | Loading... |
Feb 21, 2020 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
Feb 21, 2020 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
Feb 21, 2020 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
Feb 21, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Feb 21, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Feb 19, 2020 | ALIE | A | ASSIGNED TO LIE | Loading... |
Feb 13, 2020 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
Aug 14, 2019 | GNS2 | O | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | Loading... |
Aug 14, 2019 | GNSI | S | INQUIRY TO SUSPENSION E-MAILED | Loading... |
Aug 14, 2019 | CNSI | R | SUSPENSION INQUIRY WRITTEN | Loading... |
Feb 11, 2019 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
Feb 11, 2019 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
Feb 11, 2019 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
Feb 9, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Feb 8, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Feb 8, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Aug 13, 2018 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Aug 13, 2018 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Aug 13, 2018 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Aug 8, 2018 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
May 11, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
May 5, 2018 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Diagnostic preparations, diagnostic agents and diagnostic substances for scientific purposes, in particular immobilized proteins, cells or viruses or components thereof, nucleic acid sequences, biomarker and biological tissue cultures on a carrier material in the nature of a biochip; all of the foregoing used for qualitative proof of up to one hundred gene sequences per reaction carrier
Class 005
Diagnostic agents, in particular diagnostic agents for medical and veterinary purposes; Diagnostic agents for medical and veterinary purposes; Diagnostic agents for medical and veterinary purposes, namely, immobilized proteins, cells or viruses or components thereof, nucleic acid sequences, biomarker and biological tissue cultures on a support material in the nature of a biochip; Reagents for medical and veterinary diagnostics; Reagents for medical and veterinary diagnostics, namely, immobilized proteins, cells or viruses or components thereof, nucleic acid sequences, biomarker and biological tissue cultures on a support material in the nature of a biochip; all of the foregoing used for qualitative proof of up to one hundred gene sequences per reaction carrier
Class 009
Measuring, detecting and monitoring devices, namely, medical laboratory research instruments for preparing, processing and evaluating diagnostic samples; Sensors and detectors, namely, medical laboratory research instruments for detecting UV fluorescence and chemiluminescence for preparing, processing and evaluating diagnostic samples; Apparatuses for recording, transmission and reproduction of diagnostic data, sound and images, namely, cameras, microscopes, photometers, microplate photometers, enzyme linked immunosorbent assay readers, photomultiplier, and microplate readers; Laboratory software for recording, transmitting and reproducing diagnostic data, sound and images; all of the foregoing used for qualitative proof of up to one hundred gene sequences per reaction carrier
Class 010
Medical apparatus and instruments for medical examinations and medical diagnosis, namely, sample preparation devices for medical diagnostic uses, in particular for determining neurological diseases, infectious diseases, autoimmune diseases, allergies and cancer; all of the foregoing used for qualitative proof of up to one hundred gene sequences per reaction carrier
Additional Information
Pseudo Mark
EURO ARRAY
Classification
International Classes
001
005
009
010